Vycor Medical Inc
VYCO· OTC
Filed May 15, 2012 · 10-Q · 45 days after period end · 0001145443-12-000732
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $432.60K | $145.12K |
| Net Income | -$783.43K | -$935.70K |
| EPS Diluted | -$0.14 | -$0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 15, 2012 · 45 d after period end